Nanobiotech
NanoBiotech is a life science company that discovers, develops, and manufactures novel nanobiotics designed to improve people's health through the treatment of diseases associated with pathological calcification, inflammation and nanobacterial infections. Our Founders' pioneering research has established the role of Nanobacteria in pathological calcification: particularly in the development of heart disease, coronary artery disease, kidney stones, gallstones, polycystic kidney disease (PKD), chronic prostatitis (CP) and dermatology disorders (eczema, psoriasis, lichen planus and scleroderma ).
Our nanobiotics (NanobacTX, Urobac & Dermabac) have been proven in published clinical studies to be effective in reversing multiple chronic diseases. Our pioneering scientific & clinical research was conducted in collaboration with Mayo Clinic, Cleveland Clinic, NASA, Washington Hospital Medical Center, Scripps, Stanford, USC and continues Worldwide.
At NanoBiotech, our goal is to cure diseases, not just treat the symptoms. We provide new clinical pathways for patients & their physicians.
7932 W. Sand Lake Road #106
Orlando, Florida 32819 USA
866-568-0178
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||